Nektar Therapeutics
formerly NektarIPOPioneering science to transform patient lives through innovative immunology therapies
Public · San Francisco, United States · Founded 1990 · $460.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 1990
- Business Model
- B2B
- Website
- nektar.com
- Total Funding
- $460.0M
- Last Round
- $460.0M Corporate RoundFeb 2026
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Nektar Therapeutics is a clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 1990, Nektar has led development in PEGylation technology — attaching polyethylene glycol (PEG) polymer chains to drug molecules to improve their pharmacokinetics. The company subsequently pivoted to immunology, developing novel small-molecule and biologic therapies for conditions including atopic dermatitis and multiple sclerosis. Its lead asset NKTR-0165 demonstrated strong Phase 2b results in eczema in early 2026. Nektar went public in 1994 (Nasdaq: NKTR).
Summary
Nektar Therapeutics is a Biotech company based in San Francisco, United States, founded in 1990. It has raised $460.0M in total across 1 round, most recently a $460.0M Corporate Round in Feb 2026.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Feb 2026
Sign up to see all 4 events
Funding: Corporate Round. Amounts, valuations, and investors where available.
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nektar-therapeutics"><img src="https://indexed.vc/api/badge/company/nektar-therapeutics" alt="Nektar Therapeutics on Indexed.vc" width="260" height="76" /></a>